PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Elisa Ventura

Temple University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 11, 2026 · JOURNAL ARTICLE

Functional characterization of FAM120A as a novel effector in the progranulin/EphA2 oncogenic axis in bladder cancer

Journal of Experimental & Clinical Cancer Research

This is a mechanistic, discovery-phase study identifying a novel protein interaction in cancer cell lines and xenografts, without clinical validation or human efficacy data to support therapeutic claims.

Hypothesis-GeneratingElisa Ventura Gabriel Pascal Vrunda Satasiya

Study details

DesignIn vitro mechanistic study with cell line a…

InterventionFAM120A depletion via lentiviral short hair…

ComparatorControl cells with intact FAM120A; progranu…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support